XOMA (XOMAO) News Today $25.38 -0.12 (-0.47%) Closing price 03:20 PM EasternExtended Trading$25.38 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock XOMAO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Xoma Royalty to Acquire Lava TherapeuticsAugust 4, 2025 | marketwatch.comHillevax Shares Gain on Acquisition Deal with XOMA RoyaltyAugust 4, 2025 | msn.comXoma strikes deals to buy struggling biotechs HilleVax, LavaAugust 4, 2025 | finance.yahoo.comXoma Royalty to Acquire HilleVaxAugust 4, 2025 | marketwatch.comXOMA Royalty to acquire cancer drug developer LAVA TherapeuticsAugust 4, 2025 | msn.comXoma Royalty to Acquire Lava Therapeutics -- UpdateAugust 4, 2025 | marketwatch.comXOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last? - NasdaqJune 26, 2025 | nasdaq.comXOMA Royalty Stock Dividends | NASDAQ:XOMAO | BenzingaApril 22, 2025 | benzinga.comXoma completes sale of Kinnate Pipeline assets for up to $270MApril 15, 2025 | markets.businessinsider.comBig moves by small biotechs signal potential shift for investorsApril 15, 2025 | bizjournals.comXOMA Royalty Corporation's (NASDAQ:XOMA) Path To ProfitabilityApril 15, 2025 | finance.yahoo.comThe Analyst Verdict: XOMA Royalty In The Eyes Of 4 ExpertsMarch 28, 2025 | benzinga.comXOMA Royalty Corporation: XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business AchievementsMarch 18, 2025 | finanznachrichten.deXoma reports Q4 net loss $4M vs net loss $20.1M last yearMarch 17, 2025 | markets.businessinsider.comXOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%March 2, 2025 | finance.yahoo.comXoma price target lowered to $104 from $123 at H.C. WainwrightFebruary 3, 2025 | markets.businessinsider.comXOMA stock price target cut to $104 by H.C. WainwrightFebruary 3, 2025 | msn.comForecasting The Future: 5 Analyst Projections For XOMA RoyaltyFebruary 3, 2025 | benzinga.comXOMA Royalty CorpSeptember 18, 2024 | morningstar.comMXOMA Royalty Corporation (XOMAO)August 27, 2024 | finance.yahoo.comGlobal Net Lease, Inc. (GNL-PE)August 24, 2024 | uk.finance.yahoo.comBuy Rating Affirmed: Xoma’s Strategic Growth and Financial Strength HighlightedAugust 15, 2024 | markets.businessinsider.comTD Cowen Keeps Their Hold Rating on Xoma (XOMA)August 13, 2024 | markets.businessinsider.comXOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net LossMay 10, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: Exelixis (EXEL), Cyclo Therapeutics (CYTH)May 1, 2024 | markets.businessinsider.comLigand: Buy This Pharma Royalty Aggregator To Generate Growth In Your PortfolioApril 29, 2024 | seekingalpha.comRecap: XOMA Q4 EarningsMarch 8, 2024 | benzinga.comXOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023March 8, 2024 | finance.yahoo.comXOMA (Nasdaq:XOMAO) HeadlineTrading was temporarily halted for "XOMAO" at 07:02 AM with a stated reason of "News pending."...February 16, 2024 | marketbeat.com Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAO and its competitors with MarketBeat's FREE daily newsletter. Email Address XOMAO Media Mentions By Week XOMAO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMAO News Sentiment▼-0.310.38▲Average Medical News Sentiment XOMAO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMAO Articles This Week▼60▲XOMAO Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AIMDW News BCTXW News COCP News ENGNW News FBIOP News GLPG News GOVXW News JSPRW News LEXXW News NTHI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMAO) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
